AstraZeneca PLC (NASDAQ:AZN)
| 67.43 Delayed Data As of Sep 28 |  -0.51 / -0.75%Today’s Change | 53.24 Today|||52-Week Range 76.56 | -0.55% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 24.7B | 22.9B | 22.7B | 22.1B | |
| Cost of Goods Sold | 3.4B | 3.3B | 3.4B | 3.4B | ||
| Depreciation And Amortization | 2.7B | 2.3B | 2.5B | 2.8B | ||
| Operating Expenses | Gross Income | 18.6B | 17.4B | 16.8B | 15.8B | |
| General Expenses | 15.0B | 13.8B | 13.3B | 14.0B | ||
| Other Operating Expenses | -113.8M | 0.00 | 0.00 | 0.00 | ||
| Research And Development | 5.6B | 5.6B | 5.5B | 5.3B | ||
| Total Operating Expenses | 21.0B | 19.4B | 19.2B | 20.2B | ||
| Non-Operating Expenses | Operating Income | 3.7B | 3.6B | 3.5B | 1.8B | |
| Extraordinary Credit | 387.4M | 996.4M | 32.3M | 373.4M | ||
| Extraordinary Charge | -2.1B | -2.1B | -2.3B | -1.5B | ||
| Interest Expense On Debt | 391.4M | 615.4M | 671.1M | 739.7M | ||
| Equity In Earnings | -16.0M | -32.9M | -55.6M | -112.8M | ||
| Other Expenses | 1.4B | 1.7B | 1.6B | 2.0B | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 3.1B | 3.6B | 2.3B | 2.1B | |
| Income Taxes | -242.6M | -145.6M | -647.9M | -56.9M | ||
| Minority Interest | -998.4K | -92.8M | -134.4M | -104.8M | ||
| Net Income | 2.8B | 3.5B | 3.0B | 2.2B | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 2.5B | 2.5B | 2.5B | 2.5B | |
| Shares To Calculate EPS Diluted | 2.5B | 2.5B | 2.5B | 2.5B | ||
| Earnings Per Share | EPS | $1.11 | $1.38 | $1.20 | $0.85 | |
| EPS Diluted | $1.11 | $1.38 | $1.20 | $0.85 | ||